'This vaccine isn't just Moderna's, it was developed in collaboration with a government agency,' said one campaigner. 'It should be available and affordable for everyone, everywhere.'
that "as early as January 2023, the administration anticipates no longer having federal funds to purchase or distribute vaccines and will need to transition these activities to the commercial market, similar to seasonal flu or other commercially available vaccines."Tuesday that "the federal government has paid far less for the company's vaccine than the potential price for commercial insurers.
"The suggested average price for Covid-19 vaccines after commercialization is significantly higher than the commercial price for the annual flu vaccine , and could be a cost barrier for the uninsured and underinsured, who have no guaranteed mechanism for receiving COVID-19 vaccines once federal supplies are depleted," KFF observed.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna’s COVID shot to generate $5.0 billion in sales in 2023Shares of Moderna Inc. were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its...
Read more »
WSJ: Moderna may charge up to $130 per dose of its COVID shotShares of Moderna Inc. were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its...
Read more »
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 VaccineModerna is considering a price of $110-$130 for its Covid-19 vaccine after distribution shifts from government contracting to the commercial market
Read more »
Moderna’s Bancel Prepares for Transition Year as COVID Vaccine Sales Wane(Bloomberg) — Moderna Inc. is looking for potential approval of two new vaccines this year to help compensate for waning sales of its Covid-19 shot, according to Chief Executive Officer Steph…
Read more »
Moderna considers pricing COVID vaccine at $110-$130 - WSJModerna Inc is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company's Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday.
Read more »
Moderna Weighs Jacking Price of Its COVID Jab to $130: ReportModerna is chewing over a nearly five-fold price increase for its COVID-19 vaccine as the company prepares to roll the jabs out to commercial buyers, and is considering a number between $110 and $130, according to reports.
Read more »